Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

We conducted a pooled analysis of 869 individual newly diagnosed elderly patient data from 3 prospective trials. At diagnosis, a geriatric assessment had been performed. An additive scoring system (range 0-5), based on age, comorbidities, and cognitive and physical conditions, was developed to ident...

Celý popis

Podrobná bibliografia

Vydané v:	Blood Ročník 125; číslo 13; s. 2068
Hlavní autori:	Palumbo, Antonio, Bringhen, Sara, Mateos, Maria-Victoria, Larocca, Alessandra, Facon, Thierry, Kumar, Shaji K, Offidani, Massimo, McCarthy, Philip, Evangelista, Andrea, Lonial, Sagar, Zweegman, Sonja, Musto, Pellegrino, Terpos, Evangelos, Belch, Andrew, Hajek, Roman, Ludwig, Heinz, Stewart, A Keith, Moreau, Philippe, Anderson, Kenneth, Einsele, Hermann, Durie, Brian G M, Dimopoulos, Meletios A, Landgren, Ola, San Miguel, Jesus F, Richardson, Paul, Sonneveld, Pieter, Rajkumar, S Vincent
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 26.03.2015
Predmet:	Aged Aged, 80 and over Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Clinical Trials as Topic Cohort Studies Frail Elderly Geriatric Assessment Humans Multiple Myeloma - drug therapy Multiple Myeloma - mortality Prognosis Withholding Treatment - statistics & numerical data
ISSN:	1528-0020, 1528-0020
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!